Feasibility and Acceptability of a REDCap-Embedded HIPAA-Compliant Text Messaging Application to Track Medication Adherence in Adolescents With Lupus.
Journal
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
ISSN: 1536-7355
Titre abrégé: J Clin Rheumatol
Pays: United States
ID NLM: 9518034
Informations de publication
Date de publication:
01 Oct 2024
01 Oct 2024
Historique:
medline:
1
10
2024
pubmed:
1
10
2024
entrez:
1
10
2024
Statut:
aheadofprint
Résumé
Despite advances in clinical care and treatment options, adolescents with lupus continue to experience adverse health outcomes. Poor adherence to medication regimens is a major contributor to these negative outcomes. The utility of short message service (SMS) in tracking barriers to adherence prospectively remains untested for adolescents with lupus. Our objectives were (1) feasibility of incorporating a Health Insurance Portability and Accountability Act (HIPAA)-compliant SMS text messaging application into REDCap and (2) acceptability of using SMS text messaging to track barriers to medication adherence in adolescents with lupus. This study is a 12-week pilot cohort study of adolescents with SLE per the 1997 revised American College of Rheumatology. A REDCap-embedded HIPAA-compliant text messaging application was used to send biweekly messages with survey link to track medication adherence. Measures were completed. Descriptive statistics were used to summarize demographics, medical, and acceptability data. Response to text messages and survey completion rates were reported as a measure of feasibility. Most eligible adolescents approached agreed to participate (n = 17, 71% enrollment rate). The cellphone ownership rate among adolescents eligible for participation was 92%. Nine subjects responded to all text messages sent (53% response and completion rate). Eleven subjects (65%) responded to two thirds of the text messages. Overall, 77% of enrolled subjects completed at least half of the surveys sent. Reminders to complete surveys were sent to 30% of enrolled adolescents. This study shows that embedding a HIPAA-compliant SMS text message application in REDCap is feasible and can be used to engage adolescents with chronic conditions in monitoring between clinic visits.
Sections du résumé
BACKGROUND/OBJECTIVE
OBJECTIVE
Despite advances in clinical care and treatment options, adolescents with lupus continue to experience adverse health outcomes. Poor adherence to medication regimens is a major contributor to these negative outcomes. The utility of short message service (SMS) in tracking barriers to adherence prospectively remains untested for adolescents with lupus. Our objectives were (1) feasibility of incorporating a Health Insurance Portability and Accountability Act (HIPAA)-compliant SMS text messaging application into REDCap and (2) acceptability of using SMS text messaging to track barriers to medication adherence in adolescents with lupus.
METHODS
METHODS
This study is a 12-week pilot cohort study of adolescents with SLE per the 1997 revised American College of Rheumatology. A REDCap-embedded HIPAA-compliant text messaging application was used to send biweekly messages with survey link to track medication adherence. Measures were completed. Descriptive statistics were used to summarize demographics, medical, and acceptability data. Response to text messages and survey completion rates were reported as a measure of feasibility.
RESULTS
RESULTS
Most eligible adolescents approached agreed to participate (n = 17, 71% enrollment rate). The cellphone ownership rate among adolescents eligible for participation was 92%. Nine subjects responded to all text messages sent (53% response and completion rate). Eleven subjects (65%) responded to two thirds of the text messages. Overall, 77% of enrolled subjects completed at least half of the surveys sent. Reminders to complete surveys were sent to 30% of enrolled adolescents.
CONCLUSIONS
CONCLUSIONS
This study shows that embedding a HIPAA-compliant SMS text message application in REDCap is feasible and can be used to engage adolescents with chronic conditions in monitoring between clinic visits.
Identifiants
pubmed: 39352307
doi: 10.1097/RHU.0000000000002142
pii: 00124743-990000000-00252
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Yen EY, Singh RR. Brief report: lupus—an unrecognized leading cause of death in young females: a population-based study using nationwide death certificates, 2000–2015. Arthritis Rheumatol. 2018;70:1251–1255. doi:10.1002/art.40512.
doi: 10.1002/art.40512
Joo YB, Park SY, Won S, et al. Differences in clinical features and mortality between childhood-onset and adult-onset systemic lupus erythematosus: a prospective single-center study. J Rheumatol. 2016;43:1490–1497. doi:10.3899/jrheum.151129.
doi: 10.3899/jrheum.151129
Emamikia S, Gentline C, Enman Y, et al. How can we enhance adherence to medications in patients with systemic lupus erythematosus? Results from a qualitative study. J Clin Med. 2022;11:1857. Article. doi:10.3390/jcm11071857.
doi: 10.3390/jcm11071857
McGrady ME, Brown GA, Pai AL. Medication adherence decision-making among adolescents and young adults with cancer. Eur J Oncol Nurs. 2016;20:207–214. doi:10.1016/j.ejon.2015.08.007.
doi: 10.1016/j.ejon.2015.08.007
Lawson EF, Hersh AO, Applebaum MA, et al. Self-management skills in adolescents with chronic rheumatic disease: a cross-sectional survey. Pediatr Rheumatol Online J. 2011;9:35. doi:10.1186/1546-0096-9-35.
doi: 10.1186/1546-0096-9-35
Harry O, Crosby LE, Smith AW, et al. Self-management and adherence in childhood-onset systemic lupus erythematosus: what are we missing? Lupus. 2019;28:642–650. doi:10.1177/0961203319839478.
doi: 10.1177/0961203319839478
Eppes EV, Augustyn M, Gross SM, et al. Engagement with and acceptability of digital media platforms for use in improving health behaviors among vulnerable families: systematic review. J Med Internet Res. 2023;25:e40934. doi:10.2196/40934.
doi: 10.2196/40934
Gutierrez-Colina AM, Smith AW, Mara CA, et al. Adherence barriers in pediatric epilepsy: from toddlers to young adults. Epilepsy Behav. 2018;80:229–234. doi:10.1016/j.yebeh.2018.01.031.
doi: 10.1016/j.yebeh.2018.01.031
National Institute of Arthritis Musculoskeletal and Skin Diseases, Department of Health and Human Services. Strategic Plan for Patient-Centric Approaches to Health and Disease. Available at: https://www.niams.nih.gov/about-niams/strategic-plan-fiscal-years-2020-2024. Accessed May 14, 2024.
Aberle T, Bourn RL, Chen H, et al. Use of SLICC criteria in a large, diverse lupus registry enables SLE classification of a subset of ACR-designated subjects with incomplete lupus. Lupus Sci Med. 2017;4:e000176. doi:10.1136/lupus-2016-000176.
doi: 10.1136/lupus-2016-000176
Harry O, Crosby LE, Mara C, et al. Feasibility and acceptability of an innovative adherence intervention for young adults with childhood-onset systemic lupus erythematosus. Pediatr Rheumatol Online J. 2020;18:36. doi:10.1186/s12969-020-00430-z.
doi: 10.1186/s12969-020-00430-z
Schwartz LA, Daniel LC, Henry-Moss D, et al. Feasibility and acceptability of a pilot tailored text messaging intervention for adolescents and young adults completing cancer treatment. Psychooncology. 2020;29:164–172. doi:10.1002/pon.5287.
doi: 10.1002/pon.5287
Ting TV, Kudalkar D, Nelson S, et al. Usefulness of cellular text messaging for improving adherence among adolescents and young adults with systemic lupus erythematosus. J Rheumatol. 2012;39:174–179. doi:10.3899/jrheum.110771.
doi: 10.3899/jrheum.110771
Park LG, Howie-Esquivel J, Dracup K. A quantitative systematic review of the efficacy of mobile phone interventions to improve medication adherence. J Adv Nurs. 2014;70:1932–1953. doi:10.1111/jan.12400.
doi: 10.1111/jan.12400
Lavielle M, Puyraimond-Zemmour D, Romand X, et al. Methods to improve medication adherence in patients with chronic inflammatory rheumatic diseases: a systematic literature review. RMD Open. 2018;4:e000684. Article. doi:10.1136/rmdopen-2018-000684.
doi: 10.1136/rmdopen-2018-000684